Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 57Breast 40Other hematologic neoplasm 21Genitourinary 15Sarcoma 14Thoracic 12CNS 10Plasma cell 8Gynecologic 7Endocrine 4Classical hematology 4Tumor-Agnostic 3Head & Neck 3Other solid neoplasm 2Gastrointestinal 2Dermatologic 2Other 1NET 1

Conditions

Neutropenia 2Febrile Neutropenia 2Drug-Related Side Effects and Adverse Reactions 2Breast Neoplasms 2Thrombocytopenia 1Lymphoma 1Lung Neoplasms 1Intraocular Lymphoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anemia 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 79fludarabine phosphate 75Busulfan 53Whole-Body Irradiation 51Mycophenolic Acid 50Cyclosporine 47Peripheral Blood Stem Cell Transplantation 46fludarabine 42Antilymphocyte Serum 37Melphalan 36Tacrolimus 35Filgrastim 30Cord Blood Stem Cell Transplantation 27Radiotherapy 23Methotrexate 22Cytarabine 22Methylprednisolone 19Granulocyte Colony-Stimulating Factor 18apixaban 17Thiotepa 17Dalteparin 13thymoglobulin 12Rivaroxaban 12Alemtuzumab 12eltrombopag 11ferric carboxymaltose 10Surveys and Questionnaires 10Etoposide 10Epoetin Alfa 10Cyclosporins 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × pegfilgrastim × Classical hematology × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Asan Medical Center

Phase 2 Terminated
22 enrolled
BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT00536081 2019-11-06

Various G-CSF Regimens to Prevent Infection During Chemotherapy

Academisch Ziekenhuis Maastricht

Phase 3 Completed
172 enrolled
BreastClassical hematology

Breast Neoplasms, Febrile Neutropenia

NCT00077311 2016-06-30

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
160 enrolled
Classical hematologyThoracic

Adenocarcinoma of Lung, Anemia, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutropenia, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡